There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NVO shares. View NVO analyst ratings or view top-rated stocks.
Should you buy Novo Nordisk A/S (NVO)?
8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Novo Nordisk A/S in the last year. There are currently 2 hold ratings and 6 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" NVO shares.
Does Novo Nordisk (NVO) pay a dividend?
Novo Nordisk A/S (NYSE:NVO) pays an annual dividend of $1.33 per share and currently has a dividend yield of 1.00%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 45.86%. This payout ratio is at a healthy, sustainable level, below 75%.
